Clinical Trial Update: Evaluate Tolerability and Safety of HY209 in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating tolerability and safety of HY209 in healthy volunteers, sponsored by Kukjeon Pharmaceutical Co.,Ltd., with dementia lis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dementia

Drugs mentioned

• HY209

Snippet

Sponsor: Kukjeon Pharmaceutical Co.,Ltd. | Conditions: Dementia | Phase 1 | Status: ENROLLING_BY_INVITATION